@chanelica.r's GLP-1 video gets basic facts wrong

What did @chanelica.r actually say?

Straight answer: nothing about GLP-1 medications, weight loss, or health at all. The transcript is song lyrics, specifically the phrase "I wanna feel you, you wanna taste, taste, taste, don't I get you gone?" That is the entirety of the spoken content. There are no medical claims, dosing instructions, product endorsements, or health advice of any kind in this video.

The video was categorized under GLP-1 receptor agonists, which cover drugs like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide, and retatrutide. But nothing in the transcript connects to that category. It is possible the platform's algorithm or tagging system placed this video in a health category based on account behavior, audience demographics, or adjacent content, rather than anything the creator actually said.

Does the science back this up?

There is no scientific claim here to evaluate. The transcript contains zero propositions about biology, pharmacology, metabolism, or clinical outcomes. Fact-checking requires a claim. This video does not provide one.

That said, the GLP-1 category this video was filed under does have a substantial evidence base. Semaglutide, for instance, was studied in the SURMOUNT and STEP trial series, with researchers like Wilding et al. (2021, New England Journal of Medicine) showing significant body weight reductions in adults with obesity. Tirzepatide has similarly strong data from Jastreboff et al. (2022, NEJM). None of that is relevant to evaluating a video that consists entirely of song lyrics, but it is worth noting for anyone who landed here expecting health information.

What did they get wrong (or right)?

The creator got nothing wrong medically, because the creator said nothing medical. Credit where it is due: not making health claims is, genuinely, the right call. The GLP-1 space on TikTok is littered with creators overstating weight loss outcomes, recommending off-label stacks, or implying compounded semaglutide is equivalent to brand-name Wegovy. This video does none of that.

What is worth flagging is the category mismatch. A 3.2 million view video tagged or categorized as GLP-1 content, when it contains no GLP-1 information, represents a real problem for anyone using TikTok as a health information source. People searching for drug information may land on content that has nothing to do with their query, or vice versa, content that is actually about dangerous drug use may evade health-category scrutiny because it sounds like a song lyric. The tagging infrastructure matters.

What should you actually know?

If you landed on this fact-check expecting information about GLP-1 medications, here is what the evidence actually supports. Semaglutide and tirzepatide are FDA-approved for weight management and type 2 diabetes, with clinical trial data showing meaningful reductions in body weight and cardiovascular risk markers. They are not appropriate for everyone. They carry known risks including nausea, pancreatitis, and thyroid C-cell tumor risk in rodent models, with the human relevance still under study per the FDA prescribing information.

Compounded versions of these drugs are not equivalent to brand-name formulations. The FDA has repeatedly stated that compounded semaglutide is not FDA-approved and does not carry the same safety and efficacy guarantees. Anyone considering GLP-1 therapy should speak with a licensed clinician, not make decisions based on TikTok content, including content that accidentally got filed under a health category.